Soluble st2 as a cardiovascular disease marker and therapeutic target
CA 2484897 C · Owner: The Brigham And Women'S Hospital, Inc. · Inventors: Lee, Richard T.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention pertains to methods for predicting outcome of a cardiovascular condition in a subject, diagnosing a cardiovascular condition in a subject evaluating the , likelihood that a subject will benefit from treatment with an agent for reducing the risk of a , cardiovascular condition selecting a treatment for reducing the risk of a cardiovascular , condition for a subject selecting a subject for treatment for reducing the risk of a , cardiovascular condition, and selecting a subject for participation in a cardiovascular , condition clinical trial that include determining a level of soluble ST2 in a sample from the , subject. In particular the invention relates to methods for …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 9, 2003 and granted October 6, 2015. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 9, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 9, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.